Selumetinib

Selumetinib ATC Code L01EE04 : Antineoplastic and immunomodulating agents - Antineoplastic drugs - Protein kinase inhibitors - Mitogen-activated protein kinase (MEK) inhibitors - Selumetinib
Selumetinib
RoutesOral
FDA Approval Date2020-04-10
Molecular FormulaC17H15BrClFN4O3
Molecular Weight457.68 g/mol
CAS Number606143-52-6
Brand namesKoselugo

Selumetinib list of brand/trade names

    

    ATC Codes

    1. Alimentary tract and metabolisma
    2. Blood and blood forming organs
    3. Cardiovascular system
    4. Dermatological drugs
    5. Genitourinary system and reproductive hormones
    6. Systemic hormonal preparations, excluding reproductive hormones and insulins
    7. Antiinfectives for systemic use
    8. Antineoplastic and immunomodulating agents
    9. Musculoskeletal system
    10. Nervous system
    11. Antiparasitic products, insecticides and repellents
    12. Respiratory system
    13. Sensory organs
    14. Various ATC structures

    The newly added categories

    1. Tivozanib
    2. Fedratinib
    3. Tucatinib
    4. Everolimus
    5. Abemaciclib
    6. Selumetinib
    7. Gefitinib
    8. Minoxidil
    9. Diclofenac
    10. Mecillinam